Eddy Kizana

Targeted knock-down of neuronal nitric oxide synthase expression in basal forebrain with RNA interference.

Induction and prevention of severe hyperammonemia in the spfash mouse model of ornithine transcarbamylase deficiency using shRNA and rAAV-mediated gene delivery.

SUMO1-dependent modulation of SERCA2a in heart failure.

Therapeutic Prospects of Gene Therapy for Atrial Fibrillation.

Human Connexin40 Mutations Slow Conduction and Increase Propensity for Atrial Fibrillation.

Vascularized Cardiac Spheroids as Novel 3D in vitro Models to Study Cardiac Fibrosis.

Platelet-Derived Growth Factor Receptor-Alpha Expressing Cardiac Progenitor Cells Can Be Derived from Previously Cryopreserved Human Heart Samples.

Vitamin D Improves Cardiac Function After Myocardial Infarction Through Modulation of Resident Cardiac Progenitor Cells.

Directed Evolution of Adeno-Associated Virus Vectors in Human Cardiomyocytes for Cardiac Gene Therapy.

Gene Therapy Approaches to Biological Pacemakers.

Multimodality imaging, electrophysiologic, electroanatomic, and histopathologic characterization of atrial sarcoidosis presenting with sinus arrest and reentrant right atrial flutter.

Enhanced cardiac repair by telomerase reverse transcriptase over-expression in human cardiac mesenchymal stromal cells.

Bradycardia-induced polymorphic ventricular tachycardia after radiofrequency catheter ablation for right atrial flutter.

Analysis of recombinant adeno-associated viral vector shedding in sheep following intracoronary delivery.

Platelet-derived growth factor-AB improves scar mechanics and vascularity after myocardial infarction.

Development of a sheep model of atrioventricular block for the application of novel therapies.

Gene and Cell Therapy for Cardiac Arrhythmias.

Platelet derived growth factor-A (Pdgf-a) gene transfer modulates scar composition and improves left ventricular function after myocardial infarction.

Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity: Primer.

Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method.

Recombinant Adeno-Associated Viral Vector-Mediated Gene Transfer of Generates Pacemaker Cells from Ventricular Cardiomyocytes.

Assessing Recombinant AAV Shedding After Cardiac Gene Therapy.